Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sean A Dilliard"'
Autor:
Sean A. Dilliard, Daniel J. Siegwart
Publikováno v:
Nature Reviews Materials. 8:282-300
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf135badda232314a5cff3668d963ba1
https://doi.org/10.1038/s41578-022-00529-7
https://doi.org/10.1038/s41578-022-00529-7
Autor:
Lindsay T, Johnson, Di, Zhang, Kejin, Zhou, Sang M, Lee, Shuai, Liu, Sean A, Dilliard, Lukas, Farbiak, Sumanta, Chatterjee, Yu-Hsuan, Lin, Daniel J, Siegwart
Publikováno v:
Molecular pharmaceutics. 19(11)
Within the field of lipid nanoparticles (LNPs) for RNA delivery, the focus has been mainly placed on organ level delivery, which can mask cellular level effects consequential to therapeutic applications. Here, we studied a pair of LNPs with similar p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b48ab3e1b2ad785f6e56a182a7f37fdc
https://pubmed.ncbi.nlm.nih.gov/36154076
https://pubmed.ncbi.nlm.nih.gov/36154076
Autor:
Lindsay T. Johnson, Qiang Cheng, Daniel J. Siegwart, Tuo Wei, Sean A. Dilliard, Lukas Farbiak
Publikováno v:
Nature nanotechnology
CRISPR/Cas gene editing and messenger RNA (mRNA)-based protein replacement therapy hold tremendous potential to effectively treat disease-causing mutations with diverse cellular origin. However, it is currently impossible to rationally design nanopar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdfa37f0cf5d8e86b6f5d8a7ada8b636
http://europepmc.org/articles/PMC7735425
http://europepmc.org/articles/PMC7735425
Autor:
Sean A, Dilliard, Daniel J, Siegwart
Publikováno v:
Nature biomedical engineering. 6(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45e0234b522e4d6350a683dcc68ff473
https://pubmed.ncbi.nlm.nih.gov/35190679
https://pubmed.ncbi.nlm.nih.gov/35190679
Publikováno v:
Proc Natl Acad Sci U S A
Lipid nanoparticles (LNPs) are a clinically mature technology for the delivery of genetic medicines but have limited therapeutic applications due to liver accumulation. Recently, our laboratory developed selective organ targeting (SORT) nanoparticles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6af9bfee4820645be1fbe05a8208bd7
https://europepmc.org/articles/PMC8719871/
https://europepmc.org/articles/PMC8719871/
Autor:
Sean A. Dilliard, Daniel J. Siegwart
Publikováno v:
Nature Biomedical Engineering. 6:106-107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32d7ad17c8b2e4d2ce5b785cc75a8d7
https://doi.org/10.1038/s41551-022-00848-8
https://doi.org/10.1038/s41551-022-00848-8
Autor:
Qiang, Cheng, Tuo, Wei, Lukas, Farbiak, Lindsay T, Johnson, Sean A, Dilliard, Daniel J, Siegwart
Publikováno v:
Nature nanotechnology. 15(4)
CRISPR-Cas gene editing and messenger RNA-based protein replacement therapy hold tremendous potential to effectively treat disease-causing mutations with diverse cellular origin. However, it is currently impossible to rationally design nanoparticles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a5b7f0e2cc63aaece6d8b4d75c41d63
https://pubmed.ncbi.nlm.nih.gov/32251384
https://pubmed.ncbi.nlm.nih.gov/32251384
Autor:
Sean A Dilliard, Rita E. Serda, Steven A. Curley, Yuri Mackeyev, Lon J. Wilson, Jared M. Newton, Leoncio A. Vergara, Norman A. Lapin
Publikováno v:
International Journal of Nanomedicine
Norman A Lapin,1 Leoncio A Vergara,1,2 Yuri Mackeyev,3,4 Jared M Newton,1,5 Sean A Dilliard,6 Lon J Wilson,3,4 Steven A Curley,1 Rita E Serda1,7 1Michael E DeBakey Department of Surgery, Baylor College of Medicine, 2Institute of Biosciences & Technol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53a77e17a2a9c2b919f5c2f0432d6d4
https://doi.org/10.2147/ijn.s138641
https://doi.org/10.2147/ijn.s138641
Autor:
Martyna Krzykawska-Serda, Lon J. Wilson, Sean A Dilliard, Yuri Mackeyev, Stuart J. Corr, Steven A. Curley, Maciej Serda, Norman A. Lapin
The aim of this study is to understand the combined and differential biokinetic effects of radiofrequency (RF) electric-field hyperthermia as an adjunctive therapy to [60]fullerene nanoparticle-based drug delivery systems in targeting the microvascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1694c5314b67b82feba59442f10aac
https://europepmc.org/articles/PMC5549922/
https://europepmc.org/articles/PMC5549922/